Exploring the feasibility and utility of exome-scale tumour sequencing in a clinical setting-Reference-Cited by-同舟云学术

Exploring the feasibility and utility of exome-scale tumour sequencing in a clinical setting

Published:2018-07 Issue:7 Volume:48 Page:786-794
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Lee Belinda¹²^ORCID,Tran Ben¹²^ORCID,Hsu Arthur L.³,Taylor Graham R.³,Fox Stephen B.⁴,Fellowes Andrew⁴,Marquis Renata³,Mooi Jennifer¹,Desai Jayesh¹²,Doig Ken⁴,Ekert Paul⁵,Gaff Clara⁶,Herath Dishan¹⁷,Hamilton Anne¹⁸,James Paul⁹,Roberts Andrew¹⁰¹¹¹²,Snyder Ray¹³,Waring Paul³,McArthur Grant¹¹²

Affiliation:

1. Department of Medical Oncology; Peter MacCallum Cancer Centre; Melbourne Victoria Australia

2. Division of Systems Biology and Personalized Medicine; Walter and Eliza Hall Institute; Melbourne Victoria Australia

3. Centre for Translational Pathology; The University of Melbourne; Melbourne Victoria Australia

4. Department of Molecular Pathology; Peter MacCallum Cancer Centre; Melbourne Victoria Australia

5. Murdoch Children's Research Institute; The Royal Children's Hospital; Melbourne Victoria Australia

6. Melbourne Genomics Health Alliance; Melbourne Victoria Australia

7. Department of Medical Oncology; Western Health; Melbourne Victoria Australia

8. Department of Gynaecological Oncology; The Royal Women's Hospital; Melbourne Victoria Australia

9. Familial Cancer Centre; Peter MacCallum Cancer Centre; Melbourne Victoria Australia

10. Clinical Translation Centre; Walter and Eliza Hall Institute; Melbourne Victoria Australia

11. Department of Clinical Haematology; Peter MacCallum Cancer Centre; Melbourne Victoria Australia

12. Victorian Comprehensive Cancer Centre; St Vincent's Hospital; Melbourne Victoria Australia

13. Department of Medical Oncology; St Vincent's Hospital; Melbourne Victoria Australia

Funder

Victorian Comprehensive Cancer Centre

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imj.13806/fullpdf

Reference21 articles.

1. Cancer genomics: technology, discovery, and translation;Tran;J Clin Oncol,2012

2. The cancer genome;Stratton;Nature,2009

3. Exome sequencing takes centre stage in cancer profiling;Maher;Nature,2009

4. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial;Le Tourneau;Lancet Oncol,2015

5. Clinical interpretation and implications of whole-genome sequencing;Dewey;JAMA,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors for a broad technology assessment of comprehensive genomic profiling in advanced cancer, a systematic review;Critical Reviews in Oncology/Hematology;2024-10

2. Patient attrition in Molecular Tumour Boards: A Review;2021-10-07

3. Analysis and Interpretation of the Impact of Missense Variants in Cancer;International Journal of Molecular Sciences;2021-05-21

4. Reporting results of diagnostic NGS-based testing – user-centered redesign of the clinical report;2021-03-24

5. Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations;The Oncologist;2020-11-10